Expediting the acquisition of innovative technology through the Small Business Innovative Research (SBIR)
The Tetra Tech Federal IT Group supports federal agencies, including the Department of Defense (DoD), in accelerating solutioning on priority challenges through the Small Business Innovative Research (SBIR) program, which expedites the acquisition process to obtain innovative technology and new capability at lightning speeds.
Leveraging business process management (BPM) as a key component of successful system design and development
The Tetra Tech Federal IT Group’s Segue Technologies leverages business process management (BPM) as a key component of successful system design and development.
Any organization that needs modernization of their business systems shares the common principle of improving delivery-specific outcomes for customers or stakeholders. These outcomes are achieved through the design and implementation of connected operations, activities, and workflows—also known as business processes.
Al Jalila Children’s Specialty Hospital is on a mission to diagnose critically ill infants—and serve underrepresented patient populations
Born in Kuwait and raised in Lebanon, Dr. Ahmad Abou Tayoun developed a passion for genetics and genomics during his high school and college years in the early 2000s, when the Human Genome Project’s first draft was nearing completion. “There was a lot of excitement around the promise of the field,” he says. Abou Tayoun traveled to the United States for a PhD in genetics, a postdoc in molecular diagnostics at Dartmouth College, and a fellowship in clinical molecular diagnostics at Harvard Medical School.
Ginkgo to acquire Bayer's 175,000-square-foot Biologics R&D center and enter into a new multi-year platform collaboration with Bayer to advance several agricultural biological programs
BOSTON, July 27, 2022 /3BLMedia/ - Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, announced the signing of a definitive agreement for the previously announced transaction with Bayer to expand Ginkgo's platform capabilities in agricultural biologicals. These capabilities will be built pursuant to a transaction in which Ginkgo will acquire Bayer's 175,000-square-foot West Sacramento Biologics Research & Development site, team, and internal discovery and lead optimization platform for approximately $83.0 million in consideration.
Dr. Ranjana Bhattacharjee is using whole-genome sequencing to understand the crop’s evolution and generate improved varieties
In many tropical countries, yams are known as the “king of crops.” Worldwide, they’re the fourth most utilized root and tuber crop—after potatoes, cassavas, and sweet potatoes—and they feed hundreds of millions of people.
What is driving more ATMP manufacturers to develop multimodal facilities, evolve their equipment and push for more modern manufacturing facilities? Peter Walters, CRB’s Director of Advanced Therapies, and Matthew Hewitt, Executive Director, Scientific Solutions Cell & Gene Therapy at Charles River Laboratories, share more in ISPE’s Pharmaceutical Engineering®: http://ow.ly/IIuc50JBQbJ